195 related articles for article (PubMed ID: 28801357)
1. The Autoimmune Risk Variant
Metzler G; Dai X; Thouvenel CD; Khim S; Habib T; Buckner JH; Rawlings DJ
J Immunol; 2017 Oct; 199(7):2249-2260. PubMed ID: 28801357
[TBL] [Abstract][Full Text] [Related]
2. The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans.
Menard L; Saadoun D; Isnardi I; Ng YS; Meyers G; Massad C; Price C; Abraham C; Motaghedi R; Buckner JH; Gregersen PK; Meffre E
J Clin Invest; 2011 Sep; 121(9):3635-44. PubMed ID: 21804190
[TBL] [Abstract][Full Text] [Related]
3. The putative role of the C1858T polymorphism of protein tyrosine phosphatase PTPN22 gene in autoimmunity.
Gianchecchi E; Palombi M; Fierabracci A
Autoimmun Rev; 2013 May; 12(7):717-25. PubMed ID: 23261816
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine phosphatase PTPN22: multifunctional regulator of immune signaling, development, and disease.
Bottini N; Peterson EJ
Annu Rev Immunol; 2014; 32():83-119. PubMed ID: 24364806
[TBL] [Abstract][Full Text] [Related]
5. A switch-variant model integrates the functions of an autoimmune variant of the phosphatase PTPN22.
Vang T; Nielsen J; Burn GL
Sci Signal; 2018 Apr; 11(526):. PubMed ID: 29666305
[TBL] [Abstract][Full Text] [Related]
6. Cutting edge: the PTPN22 allelic variant associated with autoimmunity impairs B cell signaling.
Arechiga AF; Habib T; He Y; Zhang X; Zhang ZY; Funk A; Buckner JH
J Immunol; 2009 Mar; 182(6):3343-7. PubMed ID: 19265110
[TBL] [Abstract][Full Text] [Related]
7. The establishment of early B cell tolerance in humans: lessons from primary immunodeficiency diseases.
Meffre E
Ann N Y Acad Sci; 2011 Dec; 1246():1-10. PubMed ID: 22236425
[TBL] [Abstract][Full Text] [Related]
8. Altered B cell homeostasis is associated with type I diabetes and carriers of the PTPN22 allelic variant.
Habib T; Funk A; Rieck M; Brahmandam A; Dai X; Panigrahi AK; Luning Prak ET; Meyer-Bahlburg A; Sanda S; Greenbaum C; Rawlings DJ; Buckner JH
J Immunol; 2012 Jan; 188(1):487-96. PubMed ID: 22105996
[TBL] [Abstract][Full Text] [Related]
9. The autoimmune disease-associated PTPN22 variant promotes calpain-mediated Lyp/Pep degradation associated with lymphocyte and dendritic cell hyperresponsiveness.
Zhang J; Zahir N; Jiang Q; Miliotis H; Heyraud S; Meng X; Dong B; Xie G; Qiu F; Hao Z; McCulloch CA; Keystone EC; Peterson AC; Siminovitch KA
Nat Genet; 2011 Aug; 43(9):902-7. PubMed ID: 21841778
[TBL] [Abstract][Full Text] [Related]
10. Lack of the phosphatase PTPN22 increases adhesion of murine regulatory T cells to improve their immunosuppressive function.
Brownlie RJ; Miosge LA; Vassilakos D; Svensson LM; Cope A; Zamoyska R
Sci Signal; 2012 Nov; 5(252):ra87. PubMed ID: 23193160
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of the
Perry DJ; Peters LD; Lakshmi PS; Zhang L; Han Z; Wasserfall CH; Mathews CE; Atkinson MA; Brusko TM
J Immunol; 2021 Aug; 207(3):849-859. PubMed ID: 34301848
[TBL] [Abstract][Full Text] [Related]
12. A disease-associated PTPN22 variant promotes systemic autoimmunity in murine models.
Dai X; James RG; Habib T; Singh S; Jackson S; Khim S; Moon RT; Liggitt D; Wolf-Yadlin A; Buckner JH; Rawlings DJ
J Clin Invest; 2013 May; 123(5):2024-36. PubMed ID: 23619366
[TBL] [Abstract][Full Text] [Related]
13. Preparation and In Vitro Evaluation of RITUXfab-Decorated Lipoplexes to Improve Delivery of siRNA Targeting C1858T PTPN22 Variant in B Lymphocytes.
Arena A; Belcastro E; Accardo A; Sandomenico A; Pagliarosi O; Rosa E; Petrini S; Conti LA; Giorda E; Corsetti T; Schiaffini R; Morelli G; Fierabracci A
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008834
[TBL] [Abstract][Full Text] [Related]
14. Crispr/Cas Mediated Deletion of PTPN22 in Jurkat T Cells Enhances TCR Signaling and Production of IL-2.
Bray C; Wright D; Haupt S; Thomas S; Stauss H; Zamoyska R
Front Immunol; 2018; 9():2595. PubMed ID: 30483260
[TBL] [Abstract][Full Text] [Related]
15. Protein tyrosine phosphatase PTPN22 regulates LFA-1 dependent Th1 responses.
Sanchez-Blanco C; Clarke F; Cornish GH; Depoil D; Thompson SJ; Dai X; Rawlings DJ; Dustin ML; Zamoyska R; Cope AP; Purvis HA
J Autoimmun; 2018 Nov; 94():45-55. PubMed ID: 30054208
[TBL] [Abstract][Full Text] [Related]
16. Altered B cell homeostasis and toll-like receptor 9-driven response in type 1 diabetes carriers of the C1858T PTPN22 allelic variant: implications in the disease pathogenesis.
Gianchecchi E; Crinò A; Giorda E; Luciano R; Perri V; Russo AL; Cappa M; Rosado MM; Fierabracci A
PLoS One; 2014; 9(10):e110755. PubMed ID: 25333705
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis reveals an association of PTPN22 C1858T with autoimmune diseases, which depends on the localization of the affected tissue.
Zheng J; Ibrahim S; Petersen F; Yu X
Genes Immun; 2012 Dec; 13(8):641-52. PubMed ID: 23076337
[TBL] [Abstract][Full Text] [Related]
18. The common, autoimmunity-predisposing 620Arg > Trp variant of PTPN22 modulates macrophage function and morphology.
Li M; Beauchemin H; Popovic N; Peterson A; d'Hennezel E; Piccirillo CA; Sun C; Polychronakos C
J Autoimmun; 2017 May; 79():74-83. PubMed ID: 28237724
[TBL] [Abstract][Full Text] [Related]
19. PTPN22 Acts in a Cell Intrinsic Manner to Restrict the Proliferation and Differentiation of T Cells Following Antibody Lymphodepletion.
Knipper JA; Wright D; Cope AP; Malissen B; Zamoyska R
Front Immunol; 2020; 11():52. PubMed ID: 32047502
[TBL] [Abstract][Full Text] [Related]
20. Regulation of B cell homeostasis by Ptpn22 contributes to type 1 diabetes in NOD mice.
Shi X; Shao F; Li Z; Kang L; Liu J; Kissler S; Zhou Z; Jia L; Zheng P
Endocrine; 2020 Mar; 67(3):535-543. PubMed ID: 31732921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
